Documento sin título
  NEW PRODUCT  

NOVURIT (solifenacin 5 and 10 mg) is a selective competitive muscarinic acetylcholine receptor antagonist M3

It is a urinary antispasmodic of the antimuscarinic class. It is used in the treatment of overactive bladder with or without urge incontinence.

 
 
Related Bibliography  
     
BACK TO NEWS LIST  
Documento sin título